Breaking
Medicus Pharma Ltd. to Present at Biotech Showcase 2026, Advancing SkinJect ProgramEli Lilly's Legal Victory Over Noom's GLP-1 ClaimsBBSW AI Solution Event: Daily Roundup
Friday, June 19, 2026
🌏 NMPA

Regulatory Updates

🌏 NMPA Page 8

NMPA news and analysis for pharmaceutical BD, investment, and market access · 3 articles on this page

Track global pharma regulatory policy changes, FDA, EMA, and other agency guidelines impacting drug development and market access. Stay ahead.

Showing 85–87 of 87 articles

High impact NewsApr 6, 2026

PMDA Accepts Shionogi Novel Influenza Drug with SAKIGAKE Designation

PMDA · Influenza treatment · 5 min

Dr. Yuki Tanaka
Standard impact NewsApr 4, 2026

NMPA Accelerated Approval Orphan Drugs: Impact & Future Trends in China

NMPA · rare diseases · 10 min

Dr. Yuki Tanaka
High impact NewsApr 3, 2026

Pompe Disease Treatments APAC: Market Growth and Regulatory Insights

NMPA, PMDA, TGA · Rare Diseases · 5 min

Dr. Yuki Tanaka

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.